SLC5A2 and diabetes mellitus: Finally, it is worth underlining that as the inhibition of SGLT2 is not insulin-dependent, the derived renal benefits abovementioned can be obtained during any phase of the natural history of diabetes, and the only limiting factor could be a severely reduced glomerular filtration rate, as in the end-stage renal disease (ESRD).